Cargando…

Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19

Detalles Bibliográficos
Autores principales:	Zhou, Zhi-Guo, Jiang, Di-Xuan, Xie, Shu-Min, Zhang, Jing, Zheng, Fang, Peng, Hong, Chen, Xuan, Liu, Ji-Yang, Zhang, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683873/ https://www.ncbi.nlm.nih.gov/pubmed/33235253 http://dx.doi.org/10.1038/s41392-020-00407-0

Ejemplares similares

Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy
por: Min, Lulin, et al.
Publicado: (2017)

Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata
por: Yeo, In Kwon, et al.
Publicado: (2015)

Are intravenous corticosteroid pulses superior to low dose corticosteroids in patients with severe Covid-19?
por: Cordeiro Veiga, Viviane, et al.
Publicado: (2022)

Anakinra or high-dose corticosteroids in COVID-19 pneumonia patients who deteriorate on low-dose dexamethasone: an observational study of comparative effectiveness
por: Langer-Gould, Annette, et al.
Publicado: (2023)

Clinical Efficacy of Corticosteroids in the Early Stages of Deterioration in COVID-19 Pneumonia
por: Liu, Zheng, et al.
Publicado: (2021)

Severity of community-acquired pneumonia treated with low-dose adjunctive corticosteroid
por: Mikami, Katsunaka, et al.
Publicado: (2011)

High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
por: Cao, Wei, et al.
Publicado: (2020)

Efficacy and Safety Analysis of Combination Therapy Consisting of Intravenous Immunoglobulin and Corticosteroids versus Respective Monotherapies in the Treatment of Relapsed ITP in Adults
por: Fang, Lijun, et al.
Publicado: (2023)

Low dose immunoglobulin g for treatment of severe sepsis and septic shock
por: Iizuka, Y, et al.
Publicado: (2015)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19
por: Liu, Zhibo, et al.
Publicado: (2021)

Reduction in asthma deteriorations in subjects with persistent asthma uncontrolled on low-, medium-, or high-dose inhaled corticosteroids: a pooled analysis from three clinical trials using combined mometasone furoate/formoterol
por: Weinstein, SF, et al.
Publicado: (2011)

Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
por: Fang, Xiaowei, et al.
Publicado: (2020)

Posterior Reversible Encephalopathy Syndrome due to High Dose Corticosteroids for an MS Relapse
por: Morrow, Sarah A., et al.
Publicado: (2015)

Acute effect of low-dose corticosteroids on muscle function in patients with severe sepsis and septic shock
por: Borges, RC, et al.
Publicado: (2009)

Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern
por: Eftimov, Filip, et al.
Publicado: (2014)

Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post–COVID-19 Interstitial Lung Disease
por: An, Tai Joon, et al.
Publicado: (2022)

Observation on the clinical effect of high-dose Intravenous Immunoglobulin combined with low-dose prednisone acetate in the treatment of patients with Kawasaki Disease
por: Zhang, Hao, et al.
Publicado: (2021)

Spermine and spermidine reversed age-related cardiac deterioration in rats
por: Zhang, Hao, et al.
Publicado: (2017)

The Effect of Intravenous Immunoglobulin Combined with Corticosteroid on the Progression of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Meta-Analysis
por: Ye, Liang-ping, et al.
Publicado: (2016)

Using biomarkers to adjust corticosteroid dose in patients with severe asthma
por: Jones, Thomas L.
Publicado: (2021)

187 Reduction in Asthma Deteriorations in Subjects with Persistent Asthma not Well Controlled on Low-, Medium-, or High-Dose Inhaled Corticosteroids: A Pooled Analysis From Three Clinical Trials Using Combined Mometasone Furoate/Formoterol
por: Weinstein, Steven, et al.
Publicado: (2012)

Adverse events related to low dose corticosteroids in autoimmune hepatitis
por: van den Brand, Floris F., et al.
Publicado: (2019)

Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression
por: Hu, Zhiliang, et al.
Publicado: (2020)

Addition of Montelukast to Low-Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium-Dose Inhaled Corticosteroid Monotherapy
por: Ye, Young-Min, et al.
Publicado: (2015)

Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
por: Li, Yining, et al.
Publicado: (2019)

Clinical effect of montelukast sodium combined with inhaled corticosteroids in the treatment of OSAS children
por: Yang, Da-Zhi, et al.
Publicado: (2017)

Comparison of the Outcome of Low Dose and High-Dose Corticosteroid in the Treatment of Idiopathic Granulomatous Mastitis
por: Montazer, Majid, et al.
Publicado: (2020)

Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry
por: Beale, Richard, et al.
Publicado: (2010)

When to call it off: Defining the role of low-dose corticosteroids in thwarting the progression of non-severe COVID-19
por: Almas, Talal, et al.
Publicado: (2021)

Do low-dose corticosteroids improve survival or shock reversal from septic shock in adults? Meta-analysis with trial sequential analysis
por: Xu, Rui, et al.
Publicado: (2018)

Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
por: Shafiek, Hanaa, et al.
Publicado: (2021)

Nutritional status deteriorates as the severity of diabetic foot ulcers increases and independently associates with prognosis
por: ZHANG, SHAN-SHAN, et al.
Publicado: (2013)

Comment on Comparison of the Outcome of Low Dose and High-Dose Corticosteroid in the Treatment of Idiopathic Granulomatous Mastitis
por: Akbulut, Sami, et al.
Publicado: (2020)

Safety and Efficacy of Low-Dose Corticosteroids in Patients With Non-severe Coronavirus Disease 2019: A Retrospective Cohort Study
por: Almas, Talal, et al.
Publicado: (2021)

Low-Dose Corticosteroid Treatment in Children With Mycoplasma pneumoniae Pneumonia: A Retrospective Cohort Study
por: Zhang, Liya, et al.
Publicado: (2020)

A Patient with Severe Leptospirosis Treated with Cytokine Removal and High-Dose Corticosteroids
por: Fluher, Jure, et al.
Publicado: (2022)

Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose
por: Domingo, Christian, et al.
Publicado: (2023)

The airways microbiome of individuals with asthma treated with high and low doses of inhaled corticosteroids
por: Martin, Matthew J., et al.
Publicado: (2020)

Intermittent low-dose corticosteroid therapy for hidradenitis suppurativa: A case series
por: Erlendsson, Andrés M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nomj9bqo2dv0ago131lc599fgq